CAS 38916-34-6
:Somatostatin
- 1: PN: US20020156010 PAGE: 3 unclaimed protein
- 15: PN: WO2007081792 SEQID: 30 claimed protein
- 15-28-Somatostatin-28
- 243: PN: EP1170021 SEQID: 2 claimed protein
- 34: PN: WO2007058336 SEQID: 34 claimed protein
- Cyclic growth hormone release-inhibiting hormone
- Cyclic ovine somatostatin
- Cyclic somatostatin
- Cyclic somatostatin-14
- Cyclic somatotropin release-inhibitor factor
- Cyclic tetradecapeptide somatostatin
- Lampetra fluviatilis somatostatin-14
- Somatostatin
- Somatostatin (Amphiuma tridactylum)
- Somatostatin (Anguilla anguilla)
- Somatostatin (Gopherus agassizii)
- Somatostatin (human)
- Somatostatin (Lophius americanus)
- Somatostatin (Myxine glutinosa)
- Somatostatin (pigeon)
- Somatostatin (rat)
- Somatostatin (sheep reduced), cyclic (3→14)-disulfide
- Somatostatin I (Lophius americanus)
- Somatostatin SS-14
- Somatostatin-14 (Gopherus agassizii)
- Somatostatin-14 (sheep)
- Somatostatina
- Somatostatine
- Sr 9357
- Sst 14
- Stilamin
- Synthetic cyclic growth hormone release-inhibiting factor
- Synthetic cyclic growth hormone release-inhibiting hormone
- Synthetic growth hormone release-inhibiting hormone
- Synthetic somatostatin-14
- Somatostatin 14
- Somatostatin Acetate
- somatostatin gamma-irradiated*cell culture tested
- H-Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys-OH (Disulfide bond)
- alanyl-N-[19,34-bis(4-aminobutyl)-31-(2-amino-2-oxoethyl)-13,25,28-tribenzyl-4-carboxy-10,16-bis(1-hydroxyethyl)-7-(hydroxymethyl)-22-(1H-indol-3-ylmethyl)-6,9,12,15,18,21,24,27,30,33,36-undecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35-undecaazacyclooctatriacontan-37-yl]glycinamide
- Weitere Synonyme anzeigen
Somatostatin 14
CAS:For cellular and molecular biology applications
Formel:C76H104N18O19S2Molekulargewicht:1637.89Somatostatin-14
CAS:Somatostatin-14 (SRIF) was originally isolated from ovine hypothalamic extracts on the basis of its ability to inhibit the secretion of radioimmunoassayable growth hormone by primary cultures of enzymatically dispersed rat anterior pituitary cells. SRIF is a small cyclic neuropeptide hormone with broad inhibitory effects on endocrine secretions such as the production of GH, glucagon, and insulin.Formel:C76H104N18O19S2Reinheit:99.7%Farbe und Form:White PowderMolekulargewicht:1637.9Somatostatin Acetate
CAS:Formel:C76H104N18O19S2Reinheit:95%~99%Farbe und Form:White to Off-white PowderMolekulargewicht:1637.88Somatostatin Acetate
CAS:Applications Growth hormone-release inhibiting factor; treatment of severe, acute hemorrhage of gastroduodenal ulcers; experimental antidiabetic.
References Brazeau, P., et al.: Science, 179, 77 (1973), Siler, T.M., et al.: J. Clin. Endocrinol. Metab., 37, 632 (1973), Pradayrol, L., et al.: Biochem. Biophys. Res. Commun., 85, 701 (1978), Mandarino, L., et al.: Nature, 291, 76 (1981),Formel:C78H108N18O21S2Farbe und Form:NeatMolekulargewicht:1697.93Cyclic somatostatin
CAS:Cyclic somatostatin (SRIF-14) is a cyclic tetradecapeptide regulating many endocrine and nervous system functions.Formel:C76H104N18O19S2Reinheit:96.86%Farbe und Form:PowderMolekulargewicht:1637.88Somatostatin extrapure, 97%
CAS:Formel:C76H104N18O19S2Reinheit:min. 97%Farbe und Form:White to off-white, PowderMolekulargewicht:1637.88Somatostatin (Human, Ovine, Porcine, Rat, Mouse)
CAS:Somatostatin is a peptide hormone that has been found to inhibit pituitary growth hormone release as well as endocrine, pancreatic and GI secretions. It is widely expressed throughout the body for example in the gastrointestinal (GI) tract, hypothalamus, pancreas and the central nervous system. In the central nervous system somatostatin plays a role in neurotransmission modification and it has also demonstrated to be effective against a number of cancers such as squamous carcinoma. This product contains disulfide bonds between Cys3-Cys14 and is available as a 0.5mg vial.
Formel:C76H10N18O19S2Reinheit:Min. 95%Molekulargewicht:1,637.9 g/molSomatostatin
CAS:Somatostatin is a peptide hormone that is produced by the hypothalamus and inhibits the release of growth hormones, stimulates the release of insulin from the pancreas, and inhibits the release of glucagon from the pancreas. Somatostatin also has biological properties that inhibit neuronal death in combination therapy groups. It has been shown to have cell factor activity which may contribute to its antitumor activity. Somatostatin also has pro-apoptotic properties in vitro assays at physiological levels, making it an excellent target for cancer therapy.
Formel:C76H104N18O19S2Reinheit:Min. 95%Molekulargewicht:1,637.9 g/molSomatostatin
CAS:Somatostatin is a polypeptide hormone that is produced by the body to inhibit the release of other hormones in the body. It has also been used to treat diseases such as carcinoid syndrome, intestinal disorders, and diabetes mellitus type I. Somatostatin binds to somatostatin receptors on cells, which leads to inhibition of cell growth and secretion of hormones. Somatostatin has been shown to block basic protein synthesis and energy metabolism in rat liver cells. Its receptor activity is mediated by binding with signal peptide sequences and response elements.Formel:C76H104N18O19S2Reinheit:Min. 95%Farbe und Form:PowderMolekulargewicht:1,637.88 g/molCyclic Somatostatin
CAS:Formel:C76H104N18O19S2Reinheit:97%Farbe und Form:LiquidMolekulargewicht:1637.8781599999995Ref: IN-DA00IMLT
Ausgelaufenes produkt











